About
Wilson Wolf was established in 1998 to pioneer the development of innovative mammalian cell culture devices. They have created cell culture devices for a wide variety of applications including monoclonal antibody production, living skin, corneal storage, islet transplants for type 1 diabetes, immunotherapy, and routine cell culture. Wilson Wolf is dedicated to helping scientists and businesses advance the field of healthcare through the use of their revolutionary gas-permeable cell culture device platform.
Position in the VCSift Database
- • 4,609 investors in VCSift focus on the biotech sector.
- • 62 investors are based in Saint Paul, Minnesota, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- biotech
- Location
- Saint Paul, US
Contact Information
linkedin.com/in/••••••••
Find more investors like Wilson
Search Investors